Symbols

OMDA

Omada Health·NASDAQ

--(--)

OMDA fundamentals

OMDA Q4 2025 Earnings

Omada Health (OMDA) released its earnings on Mar 5, 2026: revenue was 75.85M (YoY --), beat estimates; EPS was 0.08 (YoY --), beat estimates.

Revenue / YoY

75.85M

EPS / YoY

0.08

Report date

Mar 5, 2026

OMDA Earnings Call Summary for Q4,2025

Record Growth: 53% revenue to $260M, 55% member growth to 886,000, and first-quarter GAAP profitability.
GLP-1 Leadership: 150,000 members on GLP-1s, 80% weight retention post-discontinuation, and new prescribing capability.
AI-Driven Efficiency: 73% gross margin, 40% EBITDA conversion, and 100% engineers using AI tools.
Multi-Condition Expansion: 45%+ growth in diabetes, hypertension, and new cholesterol program with 39-point cholesterol reduction.
2026 Guidance: $312-322M revenue (22% growth), $7-15M EBITDA, with upside from GLP-1 FlexCare and prescribing.

Earnings

EPS

Revenue

Revenue & Expenses

OMDA has released its 2025 Q4 earnings report, with revenue of 75.85M, reflecting a YoY change of 58.08%, and net profit of 5.16M, showing a YoY change of 162.53%. The Sankey diagram below clearly presents OMDA's revenue sources and cost distribution.

Key Indicators

Omada Health (OMDA) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Omada Health (OMDA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Omada Health (OMDA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Omada Health (OMDA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown